BioWave
BioWave makes FDA-cleared non-opioid electrical stimulation pain relief medical devices used by 90+ pro sports teams and 34 VA hospitals.
Est. Valuation
$25M
$25,020,000 · 5× ARR estimate
Monthly Revenue (MRR)
$417K
$417,000/mo
Annual Revenue (ARR)
$5M
$5,004,000/yr
Employees
16
Founded
2007
BioWave Revenue History
Revenue history for BioWave from 2018 to 2026.
| Year | MRR | ARR | YoY Growth | Source |
|---|---|---|---|---|
| 2018 | $417,000 | $5,000,000 | — | Feb 2018 |
How BioWave Makes Money
BioWave Funding
BioWave is fully bootstrapped with no outside funding. The company has grown to $5,004,000 ARR organically.
BioWave Founders
Brad Siff
Founder and President
BioWave FAQ
How much does BioWave make?
What is BioWave's valuation?
Who founded BioWave?
Is BioWave bootstrapped?
What does BioWave do?
Companies Similar to BioWave
SaaS companies with similar tags and business models.
How We Estimate BioWave's Revenue & Valuation
Profitable tracks revenue, valuation, and other key metrics for thousands of companies using a layered confidence model. Each revenue figure on this page is tagged with one of three confidence levels:
- Verified — directly confirmed via Stripe integration or audited filings.
- Self-reported — numbers publicly shared by the founder on X, blog posts, or interviews.
- Estimated — derived from publicly available signals (traffic, employee count, pricing, comparables).
Valuation follows a hierarchy: public companies use the live market cap; private companies with disclosed funding rounds use the last reported valuation; otherwise we apply a conservative 5× ARR multiple as an estimate. Multiples vary by business model — SaaS typically sits 5–7×, profitable bootstrapped operations 3–5×, consumer brands 1–3×, marketplaces 8–12×.
These are estimates, not official figures. Official numbers — when available — will always override estimates.